Physician profile
Bruce D Cameron
NPI 1356340509
$2,151.03
in general payments reported to CMS, 2019-2025
15 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $328 · 2021: $52.60 · 2022: $48.90 · 2023: $392 · 2024: $183 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $477.94 | 2019-2025 | Clareon |
| Allergan, INC. | $435.23 | 2019-2021 | |
| Glaukos Corporation | $312.76 | 2023-2024 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Istent Trabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $263.13 | 2023-2025 | Xen Glaucoma Treatment System |
| Carl Zeiss Meditec USA, INC. | $186.01 | 2025 | Cirrus Hd-Oct |
| Rayner Intraocular Lenses Limited | $142.88 | 2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Carl Zeiss Meditec, INC. | $132.12 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.12 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $29.77 | 2023 | Lipiflow System Activator (Disposable) |
| Apellis Pharmaceuticals, INC. | $27.28 | 2025 | Syfovre |
| Kala Pharmaceuticals, INC. | $24.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.03 | 2019 | |
| Iridex Corporation | $14.62 | 2019 | |
| Aerie Pharmaceuticals, INC. | $12.27 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.